LymeX Authorization Act authorizes funding for prize competitions to innovate Lyme disease prevention, diagnosis, and treatment.
The LymeX Authorization Act aims to engage various stakeholders to drive patient-centered innovations in Lyme disease care. It seeks to foster breakthroughs in health education and public awareness, and to accelerate the development of next-generation diagnostics. The Act authorizes $5,000,000 in appropriations for the Secretary of Health and Human Services to fund prize competitions, as defined under the Stevenson-Wydler Technology Innovation Act of 1980, to spur advancements in Lyme disease prevention, diagnosis, and treatment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.